# US 2016/0354425 A1 · Methods for treating hcv

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0354425 A1
- Document ID: US20160354425A1
- Status: Published application
- Kind: A1
- Application number: 15/181,163
- Filed: 2016-06-13
- Published: 2016-12-08
- Earliest claimed: 2011-09-16
- Assignees: Gilead Pharmasset LLC
- Applicants: Gilead Pharmasset LLC
- Inventors: William E. Delaney, IV; John O. Link; Hongmei Mo; David W. Oldach; Adrian S. Ray; William J. Watkins; Cheng Yong Yang
- Web page: https://patentgrep.com/patent/US20160354425A1

## CPC

- A61K 31/7072: having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61K 9/20: Pills, tablets, {discs, rods (A61K9/0004, A61K9/0007, A61K9/0056, A61K9/0065 take precedence; for reconstitution of a drink A61K9/0095)}
- A61K 31/381: having five-membered rings
- A61K 31/4184: condensed with carbocyclic rings, e.g. benzimidazoles
- A61K 31/4196: 1,2,4-Triazoles
- A61K 31/513: having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A61K 31/7052: having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K 31/7056: containing five-membered rings with nitrogen as a ring hetero atom
- A61K 38/06: Tripeptides
- A61K 38/212: {IFN-alpha}
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 1/16: for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P 31/12: Antivirals
- A61P 31/14: for RNA viruses
- A61P 31/22: for herpes viruses
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

This invention relates to combinations of therapeutic molecules useful for treating hepatitis C virus infection. The present invention relates to methods, uses, dosing regimens, and compositions.

## Claims

### Claim 1

A composition comprising:
compound 3 having the structure:
or a pharmaceutically acceptable salt thereof; and
compound 6 having the structure:
or a pharmaceutically acceptable salt thereof.

### Claim 2 (depends on 1)

The composition of claim 1, further comprising one or more pharmaceutically acceptable diluents or carriers.

### Claim 3 (depends on 1)

The composition of claim 1, which is formulated as a unit dosage form for once daily administration.

### Claim 4 (depends on 3)

The composition of claim 3, which is formulated for oral administration.

### Claim 5 (depends on 4)

The composition of claim 4, which is formulated as a tablet.

### Claim 6 (depends on 1)

The composition of claim 1, further comprising ribavirin.
